Does BEVACIZUMAB Cause Pulmonary embolism? 1,181 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,181 reports of Pulmonary embolism have been filed in association with BEVACIZUMAB (JOBEVNE). This represents 1.5% of all adverse event reports for BEVACIZUMAB.
1,181
Reports of Pulmonary embolism with BEVACIZUMAB
1.5%
of all BEVACIZUMAB reports
303
Deaths
498
Hospitalizations
How Dangerous Is Pulmonary embolism From BEVACIZUMAB?
Of the 1,181 reports, 303 (25.7%) resulted in death, 498 (42.2%) required hospitalization, and 150 (12.7%) were considered life-threatening.
Is Pulmonary embolism Listed in the Official Label?
Yes, Pulmonary embolism is listed as a known adverse reaction in the official FDA drug label for BEVACIZUMAB.
What Other Side Effects Does BEVACIZUMAB Cause?
Off label use (12,094)
Death (8,493)
Diarrhoea (4,911)
Disease progression (4,653)
Fatigue (4,572)
Nausea (4,357)
Hypertension (4,309)
Anaemia (3,221)
Vomiting (3,193)
Neutropenia (2,875)
What Other Drugs Cause Pulmonary embolism?
RIVAROXABAN (3,282)
LENALIDOMIDE (2,976)
APIXABAN (2,714)
ETHINYL ESTRADIOL\ETONOGESTREL (2,370)
TESTOSTERONE (2,043)
RITUXIMAB (1,764)
ADALIMUMAB (1,663)
PREDNISONE (1,586)
METHOTREXATE (1,508)
DEXAMETHASONE (1,336)
Which BEVACIZUMAB Alternatives Have Lower Pulmonary embolism Risk?
BEVACIZUMAB vs BEVACIZUMAB-AWWB
BEVACIZUMAB vs BEVACIZUMAB-BVZR
BEVACIZUMAB vs BEVACIZUMAB-MALY
BEVACIZUMAB vs BEXAROTENE
BEVACIZUMAB vs BEYAZ